Cargando…

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

Rotavirus is the most common cause of diarrhea leading to hospitalization in young children. Rotavirus vaccines are available in Canada but have not been introduced in all provinces. In a controlled trial, 2 study sites (Prince Edward Island and the Capital District Health Authority (District 9, Nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanford, Carolyn, Langley, Joanne M, Halperin, Scott A, Zelman, Mitchell, Maritime Universal Rotavirus Vaccination Program, MURVP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514393/ https://www.ncbi.nlm.nih.gov/pubmed/25746110 http://dx.doi.org/10.1080/21645515.2015.1012028

Ejemplares similares

Implementation of a universal rotavirus vaccination program: comparison of two delivery systems
por: Zelman, Mitchell, et al.
Publicado: (2014)

Assessing the risk of intussusception and rotavirus vaccine safety in Canada
por: Hawken, Steven, et al.
Publicado: (2016)

Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity
por: Al-Hammadi, Suleiman, et al.
Publicado: (2020)

Rotavirus gastroenteritis in infants and young children
por: Šrámková, L., et al.
Publicado: (1979)

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada
por: Nourbakhsh, Shokoofeh, et al.
Publicado: (2021)

The effect of small amounts of boron and zirconium of the high temperature properties of vacuum-melted super alloys: project 133
por: Universal-Cyclops Steel. Bridgeville, PN
Publicado: (1956)

Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
por: Chandran, Aruna, et al.
Publicado: (2010)

The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination
por: Ang, Li, et al.
Publicado: (2014)

Escherichia coli Meningitis after Rotavirus Gastroenteritis in an Infant
por: Ozgurhan, Gamze, et al.
Publicado: (2016)

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
por: Bruijning-Verhagen, Patricia, et al.
Publicado: (2013)

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014)

Adverse infant outcomes associated with caesarean section delivery in India
por: Gondwe, Tamala, et al.
Publicado: (2019)

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
por: Shoukat, Affan, et al.
Publicado: (2023)

Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals
por: McDermid, Andrew, et al.
Publicado: (2012)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Adverse Events in Affiliated Hospitals of Mazandaran University of Medical Sciences
por: Saravi, Benyamin Mohseni, et al.
Publicado: (2014)

G2 Strain of Rotavirus among Infants and Children, Bangladesh
por: Dey, Shuvra Kanti, et al.
Publicado: (2009)

Unexpectedly high burden of rotavirus gastroenteritis in very young infants
por: Clark, H Fred, et al.
Publicado: (2010)

Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants
por: Chilengi, Roma, et al.
Publicado: (2016)

COVID-19: An opportunity to vaccinate infants against rotavirus infections
Publicado: (2020)

Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants
por: Church, James A., et al.
Publicado: (2020)

The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants
por: Robertson, Ruairi C., et al.
Publicado: (2021)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

Prevalence of Rotavirus Genotypes in Children Younger than 5 Years of Age before the Introduction of a Universal Rotavirus Vaccination Program: Report of Rotavirus Surveillance in Turkey
por: Durmaz, Riza, et al.
Publicado: (2014)

Keto-Bezoar: Adverse Event Related to Initiation of Ketogenic Diet in an Infant
por: Stegall, Cassandra, et al.
Publicado: (2022)

Differentiation between Wild-Type Group A Rotaviruses and Vaccine Strains in Cases of Suspected Horizontal Transmission and Adverse Events Following Vaccination
por: Jacobsen, Sonja, et al.
Publicado: (2022)

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
por: Lappalainen, Suvi, et al.
Publicado: (2015)

In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine
por: Kazimbaya, Katayi Mwila, et al.
Publicado: (2020)

Nosocomial Infection due to Rotavirus in Infants in Alzahra Hospital, Isfahan, Iran
por: Kordidarian, Roghayeh, et al.
Publicado: (2007)

The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)

Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants
por: Leino, Tuija, et al.
Publicado: (2016)

Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan
por: Harris, Vanessa, et al.
Publicado: (2017)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants
por: Bucardo, Filemón, et al.
Publicado: (2019)

Geospatial Variation in Rotavirus Vaccination in Infants, United States, 2010–2017
por: Rogers, Mary A.M., et al.
Publicado: (2019)

Investigating barriers to the protective efficacy provided by rotavirus vaccines in African infants
por: Bines, Julie E.
Publicado: (2021)

Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take—An Overview
por: Sharma, Sumit, et al.
Publicado: (2021)

Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain
por: Diez-Domingo, Javier, et al.
Publicado: (2010)

Flavin Adenine Dinucleotide-Related Adverse Event Necessitating Cardiopulmonary Resuscitation in an Infant
por: Fujii, Shunsuke, et al.
Publicado: (2022)

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7ieop4qlcibim427hgok4ukeag